Tevogen Bio Inc: Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive ...
The grant funding will further Tevogen Bio's mission to develop therapies for treatment of cancers and viral infections.Tevogen Bio may also utilize the grant funding to further expand its artificial ...
pharmaphorum4 天
Two more biotechs, Metsera and Maze, cross IPO finish line
Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the ...